SCHEMBL7797258

SCHEMBL7797258

COc1cc2cnc(Nc3ccc(Br)cc3F)nc2cc1OC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 14/20 0.59
EGFR P00533 13/20 0.59
RET P07949 2/20 0.59
KIF5B P33176 2/20 0.59
FLT1 P17948 12/20 0.46
FGFR1 P11362 11/20 0.46
FLT4 P35916 10/20 0.44
PDGFRB P09619 3/20 0.44
FGFR2 P21802 2/20 0.44
FGFR4 P22455 2/20 0.44
FGFR3 P22607 2/20 0.44
EPHB2 P29323 2/20 0.44
TEK Q02763 2/20 0.44
ABCG2 Q9UNQ0 2/20 0.44
EPHA2 P29317 2/20 0.44
BMPR1B O00238 1/20 0.44
PLK4 O00444 1/20 0.44
CIT O14578 1/20 0.44
GAK O14976 1/20 0.44
EPHB6 O15197 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6478589 0.91 KDR (0.49) KDREGFRRETKIF5BFLT1
SCHEMBL4780880 0.84 EGFR (0.49) KDREGFRRETKIF5BFLT1
SCHEMBL3668398 0.84 EGFR (0.69) KDREGFRRETKIF5BFLT1
SCHEMBL7791030 0.84 FLT1 (0.55) KDREGFRFLT1FGFR1FGFR2
SCHEMBL7766729 0.79 MEN1 (0.46) KDREGFRPDGFRBERBB2LCK
SCHEMBL7797381 0.79 KDM4E (0.43) KDREGFRRETKIF5BFGFR1
SCHEMBL7799235 0.79 CSF1R (0.52) KDREGFRRETKIF5BFLT1
SCHEMBL7790969 0.79 EGFR (0.55) EGFRFGFR1FGFR2FGFR4FGFR3
SCHEMBL7595199 0.78 PDGFRB (0.43) KDREGFRRETKIF5BFGFR1
SCHEMBL5446668 0.78 RAF1 (0.50) KDREGFRFLT1FGFR1FLT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1162974-A1 QUINAZOLINE FORMULATIONS AND THERAPEUTIC USE THEREOF Parker Hughes Institute (US) 2001-12-19 EP disclosed
EP-1163228-A1 QUINAZOLINES AND THERAPEUTIC USE THEREOF Parker Hughes Institute (US) 2001-12-19 EP disclosed
WO-2000056338-A1 QUINAZOLINE FORMULATIONS AND THERAPEUTIC USE THEREOF PARKER HUGHES INSTITUTE (US) 2000-09-28 WO disclosed
WO-2000056720-A1 QUINAZOLINES AND THERAPEUTIC USE THEREOF PARKER HUGHES INSTITUTE (US) 2000-09-28 WO disclosed